Literature DB >> 8601929

Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort.

R D Hurt1, K P Offord, I T Croghan, L Gomez-Dahl, T E Kottke, R M Morse, L J Melton.   

Abstract

OBJECTIVE: To determine the impact of tobacco- and alcohol-related deaths on overall mortality following inpatient treatment for alcoholism and other nonnicotine drugs of dependence.
DESIGN: Population-based retrospective cohort study.
SETTING: Olmsted County, Minnesota (the Rochester Epidemiology Project), and the Inpatient Addiction Program (IAP) at Mayo Clinic, Rochester. PATIENTS: All 845 Olmsted County residents admitted to an inpatient addiction program for treatment of alcoholism and other nonnicotine drugs of dependence during the period 1972 through 1983.
METHODS: Patients were followed up through the medical record linkage system of the Rochester Epidemiology Project through December 1994 to obtain vital status, and death certificates were obtained for those who died. The underlying cause of death was classified as alcohol related, tobacco related, both, or neither based on the classification from the Centers for Disease Control and Prevention. The observed number of deaths by underlying cause were compared with the expected number using cause-specific 1987 death rates for the white population of the United States. All-cause mortality was also compared with that expected for persons in the West North Central Region of the United States of like age, sex, and year of birth. Univariate and multivariate assessments were made to identify predictors of all-cause mortality from baseline demographic information.
RESULTS: At admission, the mean (SD) age of the 845 patients was 41.4 (14.5) years, and 35% were women. Altogether, 78% had alcohol as their only nonnicotine drug of dependence and 18% had alcohol and other nonnicotine drugs of dependence, while 4% were classified as having a nonalcohol, nonnicotine drug dependence alone. At admission, 75% were current and 8% former cigarette smokers, 3% were current cigar or pipe smokers, and 2% were current users of smokeless tobacco. Follow-up after the index IAP admission totaled 8913 person-years (mean [SD] of 10.5 [5.6] years per patient). Death certificates were obtained for 96% (214) of the 222 patients who died. Of these 214 deaths, 50.9% (109) had a tobacco-related and 34.1% (73) had an alcohol-related underlying cause (P<.001). The cumulative mortality significantly exceeded that expected (P<.001); at 20 years, the observed mortality was 48.1% vs an expected 18.5%. Multivariate predictors of mortality, even after adjusting for expected mortality, were older age at admission (P<.001) and male sex (P<.001).
CONCLUSIONS: Patients previously treated for alcoholism and/or other nonnicotine drug dependence had an increased cumulative mortality that was due more to tobacco-related than to alcohol-related causes. Nicotine dependence treatment is imperative in such high-risk patients.

Entities:  

Mesh:

Year:  1996        PMID: 8601929     DOI: 10.1001/jama.275.14.1097

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  256 in total

1.  Smoking cessation in a homeless population: there is a will, but is there a way?

Authors:  Sharon E Connor; Robert L Cook; Mary I Herbert; Stephen M Neal; Jennifer T Williams
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

2.  Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco.

Authors:  William S John; He Zhu; Paolo Mannelli; Geetha A Subramaniam; Robert P Schwartz; Jennifer McNeely; Li-Tzy Wu
Journal:  Drug Alcohol Depend       Date:  2018-11-26       Impact factor: 4.492

3.  Impulsivity is an independent predictor of 15-year mortality risk among individuals seeking help for alcohol-related problems.

Authors:  Daniel M Blonigen; Christine Timko; Bernice S Moos; Rudolf H Moos
Journal:  Alcohol Clin Exp Res       Date:  2011-06-01       Impact factor: 3.455

4.  Predictors of Tobacco Use Among New York State Addiction Treatment Patients.

Authors:  Joseph Guydish; Jiang Yu; Thao Le; Anna Pagano; Kevin Delucchi
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

5.  Chronic cigarette smoking in alcohol dependence: associations with cortical thickness and N-acetylaspartate levels in the extended brain reward system.

Authors:  Timothy C Durazzo; Anderson Mon; Stefan Gazdzinski; Dieter J Meyerhoff
Journal:  Addict Biol       Date:  2011-11-09       Impact factor: 4.280

Review 6.  Current perspectives on smoking cessation among substance abusers.

Authors:  Maria A Sullivan; Lirio S Covey
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

7.  Varenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Giulia Scuppa; Andrea Cippitelli; Lawrence Toll; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Drug Alcohol Depend       Date:  2015-09-08       Impact factor: 4.492

8.  The Untreated Addiction: Going Tobacco-Free in a VA Substance Abuse Residential Rehabilitation Treatment Program (SARRTP).

Authors:  Megan Conrad; Teri Bolte; Leigh Gaines; Zackery Avery; Linda Bodie
Journal:  J Behav Health Serv Res       Date:  2018-10       Impact factor: 1.505

9.  Bupropion-SR for smoking reduction and cessation in alcohol-dependent outpatients: a naturalistic, open-label study.

Authors:  Maher Karam-Hage; Jason D Robinson; Ashutosh Lodhi; Kirk J Brower
Journal:  Curr Clin Pharmacol       Date:  2014-05

10.  Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment.

Authors:  Damaris J Rohsenow; Rosemarie A Martin; Peter M Monti; Suzanne M Colby; Anne M Day; David B Abrams; Alan D Sirota; Robert M Swift
Journal:  J Subst Abuse Treat       Date:  2013-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.